torsemide has been researched along with Atrial Remodeling in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, O; Böhm, M; Hanke, N; Hartmann, RW; Klemmer, B; Laufs, U; Zimmer, C | 1 |
1 other study(ies) available for torsemide and Atrial Remodeling
| Article | Year |
|---|---|
Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
Topics: Aldosterone; Animals; Atrial Fibrillation; Atrial Remodeling; Cardiotonic Agents; Cells, Cultured; Connective Tissue Growth Factor; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Fibrillar Collagens; Fibroblasts; Fibrosis; Inhibitory Concentration 50; Mice; Mice, Transgenic; MicroRNAs; Protein-Lysine 6-Oxidase; Rats, Sprague-Dawley; Sulfonamides; Torsemide | 2015 |